Amantadine extended release - Adamas Pharmaceuticals
At a glance
- Drug Originator Adamas Pharmaceuticals
- Drug Class Adamantanes; Antiparkinsonians; Antivirals; Organic bridged compounds; Small molecules
- Mechanism of Action Dopamine receptor agonists; NMDA receptor antagonists
- USA Patent Applicants SUPERNUS PHARMS
- USA Patents 19
- NDAs 1
- International Patents 38
- Patent Applications 1,037

Disclaimer